WATS3D® Significantly Boosts Barrett’s Esophagus and Dysplasia Detection Rates in Landmark Clinical Study

Pivotal Multi-Center Study Highlights AI Platform’s Powerful Diagnostic Impact and Ability to Enhance Patient Outcomes SUFFERN, N.Y., May 17, 2024 /PRNewswire/ — CDx Diagnostics, Inc., developer of the WATS3D AI Platform for the detection and surveillance of Barrett’s esophagus (BE) and…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.